American Century Companies’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
Other funds holding JUNO
CM
OFM
BB
American Century Companies's JUNO Position: Q2 2015 in Review
American Century Companies sold out of Juno Therapeutics, Inc. (JUNO) in Q2 2015, closing a stake of 12,457 shares — an estimated $756K sold.
American Century Companies first reported a position in JUNO in Q4 2014 and held it in 2 quarters. The position peaked at $756K in Q1 2015. 154 funds tracked by Wall St. Rank hold JUNO as of Q2 2015.
- American Century Companies reported no remaining Juno Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
- American Century Companies sold 12,457 Juno Therapeutics, Inc. shares in Q2 2015, an estimated $756K.
- American Century Companies first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 2 quarters.
- American Century Companies's Juno Therapeutics, Inc. position peaked at $756K in Q1 2015.
- 154 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q2 2015.
Based on American Century Companies's 13F filing for Q2 2015, filed 28 Jul 2015.